These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming. Martin-Lopez M; Maeso-Alonso L; Fuertes-Alvarez S; Balboa D; Rodríguez-Cortez V; Weltner J; Diez-Prieto I; Davis A; Wu Y; Otonkoski T; Flores ER; Menéndez P; Marques MM; Marin MC Cell Death Dis; 2017 Sep; 8(9):e3034. PubMed ID: 28880267 [TBL] [Abstract][Full Text] [Related]
5. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas. Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529 [TBL] [Abstract][Full Text] [Related]
6. The polycomb protein Ezh2 impacts on induced pluripotent stem cell generation. Ding X; Wang X; Sontag S; Qin J; Wanek P; Lin Q; Zenke M Stem Cells Dev; 2014 May; 23(9):931-40. PubMed ID: 24325319 [TBL] [Abstract][Full Text] [Related]
7. Human fibroblast reprogramming to pluripotent stem cells regulated by the miR19a/b-PTEN axis. He X; Cao Y; Wang L; Han Y; Zhong X; Zhou G; Cai Y; Zhang H; Gao P PLoS One; 2014; 9(4):e95213. PubMed ID: 24740298 [TBL] [Abstract][Full Text] [Related]
8. Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2. Maleszewska M; Gjaltema RA; Krenning G; Harmsen MC Cell Signal; 2015 Aug; 27(8):1589-96. PubMed ID: 25917318 [TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial-mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract. Lu L; Luo F; Liu Y; Liu X; Shi L; Lu X; Liu Q Toxicol Appl Pharmacol; 2015 Dec; 289(2):276-85. PubMed ID: 26415832 [TBL] [Abstract][Full Text] [Related]
11. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Liu X; Sun H; Qi J; Wang L; He S; Liu J; Feng C; Chen C; Li W; Guo Y; Qin D; Pan G; Chen J; Pei D; Zheng H Nat Cell Biol; 2013 Jul; 15(7):829-38. PubMed ID: 23708003 [TBL] [Abstract][Full Text] [Related]
12. Generation of intermediate porcine iPS cells under culture condition favorable for mesenchymal-to-epithelial transition. Zhang S; Guo Y; Cui Y; Liu Y; Yu T; Wang H Stem Cell Rev Rep; 2015 Feb; 11(1):24-38. PubMed ID: 25134796 [TBL] [Abstract][Full Text] [Related]
13. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line. Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258 [TBL] [Abstract][Full Text] [Related]
14. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240 [TBL] [Abstract][Full Text] [Related]
15. Small RNA-mediated regulation of iPS cell generation. Li Z; Yang CS; Nakashima K; Rana TM EMBO J; 2011 Mar; 30(5):823-34. PubMed ID: 21285944 [TBL] [Abstract][Full Text] [Related]
16. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins. Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118 [TBL] [Abstract][Full Text] [Related]
17. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Tiwari N; Tiwari VK; Waldmeier L; Balwierz PJ; Arnold P; Pachkov M; Meyer-Schaller N; Schübeler D; van Nimwegen E; Christofori G Cancer Cell; 2013 Jun; 23(6):768-83. PubMed ID: 23764001 [TBL] [Abstract][Full Text] [Related]
18. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells. Vazquez-Martin A; Vellon L; Quirós PM; Cufí S; Ruiz de Galarreta E; Oliveras-Ferraros C; Martin AG; Martin-Castillo B; López-Otín C; Menendez JA Cell Cycle; 2012 Mar; 11(5):974-89. PubMed ID: 22333578 [TBL] [Abstract][Full Text] [Related]
19. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Li R; Liang J; Ni S; Zhou T; Qing X; Li H; He W; Chen J; Li F; Zhuang Q; Qin B; Xu J; Li W; Yang J; Gan Y; Qin D; Feng S; Song H; Yang D; Zhang B; Zeng L; Lai L; Esteban MA; Pei D Cell Stem Cell; 2010 Jul; 7(1):51-63. PubMed ID: 20621050 [TBL] [Abstract][Full Text] [Related]
20. Involvement of Polycomb Repressive Complex 2 in Maturation of Induced Pluripotent Stem Cells during Reprogramming of Mouse and Human Fibroblasts. Khazaie N; Massumi M; Wee P; Salimi M; Mohammadnia A; Yaqubi M PLoS One; 2016; 11(3):e0150518. PubMed ID: 26938987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]